Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

NCT05554302 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT05554302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Lead sponsor
Baptist Health South Florida
Phase
Phase 2
Overall status
Recruiting
Start date
January 10, 2023
Completion date
January 31, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain metastases